Extended Data Fig. 5: The changes of the cytokine and marker of inflammation and coagulopathy in serums obtained from the patients. | Nature Cancer

Extended Data Fig. 5: The changes of the cytokine and marker of inflammation and coagulopathy in serums obtained from the patients.

From: Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory/relapsed large B cell lymphoma: a phase 1 trial

Extended Data Fig. 5: The changes of the cytokine and marker of inflammation and coagulopathy in serums obtained from the patients.The alternative text for this image may have been generated using AI.

a, Serum kinetics of cytokines of eotaxin, IL-18, IL-1RA, IL-7, IP-10, MCP-1, MIP1α, MIP1β, RANTES, and SDF-1ɑ in 8 patients who received infusions with CAR-NK cells. b, Heatmap of a panel of other cytokines detected in the serum from 8 patients at pre- or post-infusion of CAR-NK cells. c, Serum levels of CRP, LDH, Fibrinogen, D-dimer, and Ferritin in 8 patients before and after CAR-NK cell infusion.

Source data

Back to article page